📄 中文摘要
麻省理工学院和微软的研究人员利用人工智能开发了分子传感器，这些传感器能够通过尿液检测癌症的早期迹象。研究团队创建了一种AI模型，设计出针对癌细胞中过度活跃的酶——蛋白酶的短肽。这些涂有特定肽的纳米颗粒能够与蛋白酶结合，从而实现对癌症的早期识别。这项技术有望为癌症的早期诊断提供新的方法，提升患者的治疗效果和生存率。
人工智能设计的蛋白质可能有助于癌症早期检测
出处: A I-designed proteins may help spot cancer
发布: 2026年2月24日
📄 English Summary
A I-designed proteins may help spot cancer
Researchers at MIT and Microsoft have developed molecular sensors using artificial intelligence that can detect early signs of cancer through a urine test. The team created an AI model to design short proteins, known as peptides, which are specifically targeted by proteases—enzymes that are overactive in cancer cells. These nanoparticles coated with the designed peptides can bind to the proteases, enabling early identification of cancer. This technology holds promise for providing new methods for early cancer diagnosis, potentially improving treatment outcomes and survival rates for patients.